DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Matthay KK, Weiss B, Villablanca JG. et al.
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
J Nucl Med 2012;
53: 1155-1163
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.